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Various entities and genetic etiologies, including inherited long QT syndrome type 3 (LQT3), contrib-
ute to sudden infant death syndrome (SIDS). The goal of our research was to biophysically charac-
terize a new SCN5A mutation (S1333Y) in a SIDS infant. S1333Y channels showed the gain of Na+
channel function characteristic of LQT3, including a persistent inward Na+ current and an enhanced
window current that was generated by a 8 mV shift in activation and a +7 mV shift in inactivation.
The correlation between the biophysical data and arrhythmia susceptibility suggested that the SIDS
was secondary to the LQT3-associated S1333Y mutation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction responsible for the initiation and propagation of the cardiac actionThe most common cause of mortality during the ﬁrst year of life
of infants in developed countries is sudden infant death syndrome
(SIDS), which is more common in infants placed in a prone position
[1] or with upper respiratory infections [2]. Other risk factors
include bottle feeding, second-hand smoke, overheating, and co-
sleeping [3]. Previous studies revealed that SIDS is associated with
alterations in genes associated with cardiac ion channels, including
human cardiac voltage-gated Na+ channels (Nav1.5) [4].
Inherited long QT syndrome (LQTS) accounts for about 9.5% of
SIDS cases, suggesting that sudden death due to cardiac arrhyth-
mias is an important contributor to SIDS [5]. LQTS is caused by
delayed ventricular repolarization, which leads to fatal ventricular
arrhythmias and even sudden death. Inherited LQT3 linked to
mutations in SCN5A has also been directly linked to SIDS [6–10].
SCN5A is the major gene known to functionally encode the a-sub-
unit of the human cardiac voltage-gated Na+ channel, which ischemical Societies. Published by E
Recherche Université Laval
anardière, Québec City, QC,
M. Chahine).potential. The hallmark of the gating change in LQT3 mutations is
the presence of persistent inward Na+ currents due to incomplete
inactivation or late re-opening of Na+ channels, as a result, QT
interval prolongation. Most LQT3 mutations are located in the
III–IV linker, various domains of the S4–S5 linkers, voltage sensors,
and the C-terminus of Na+ channels, which are associated with the
fast inactivation process. The S4–S5 linker of domain III plays a ma-
jor role in the kinetics and voltage dependence of fast inactivation
of Na+ channels by acting as a docking site for the inactivation par-
ticle of the III–IV linker [11].
In this work we report a new SIDS mutation (S1333Y) in a
25-day-old infant, which is located in the S4–S5 linker of domain
III [12], and we characterize its biophysical properties.
2. Methods
2.1. Clinical evaluation and molecular genetics
The local ethics committee approved the study protocol. The
parents provided written informed consent. The death certiﬁcate
indicated a diagnosis of SIDS, while the autopsy, toxicology, and re-
view of the circumstances of death were negative. Genomic DNAlsevier B.V. All rights reserved.
H. Huang et al. / FEBS Letters 583 (2009) 890–896 891was extracted from whole blood using a WIZARD Genomic DNA
Puriﬁcation kit (Promega, Madison, WI, USA). The coding exons
of the KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 genes were ampli-
ﬁed separately using intronic primers and previously reported PCR
conditions [13]. Denaturing high performance liquid chromatogra-
phy (DHPLC) was performed using previously described elution
proﬁles and melting temperatures [12]. PCR products with diver-
gent chromatographic proﬁles were directly sequenced on both
strands using the BigDye Terminator v.31 Cycle sequencing kit
(Applied Biosystems, Forster City, CA, USA) and were applied to
an ABI 3100 automatic sequencer.
2.2. Mutagenesis
Mutant hNav1.5/S1333Y was generated using a QuickChange
TM site-directed mutagenesis kit according to the manufacturer’s
instructions (Stratagene, La Jolla, CA, USA). The oligo-nucleotide
primers containing the corresponding S1333Y mutation were syn-
thesized using the following sequences:
50-GTG GGC GTC GCC ATC CCG TAC ATC ATG AAC GTC CTC-30
(forward primer) and 50-GAG GAC GAG GTT CAT GAT GTA CGG
GAT GGC GCC CAC-30 (reverse primer).
The mutated site is underlined. Mutant andWT Nav1.5 channels
were inserted in a pcDNA1 construct and were puriﬁed using
Qiagen columns (Qiagen Inc., Chatsworth, CA, USA).
2.3. TsA201 transfection and patch clamp experiments
Mutant channels were coexpressed with the b subunit in the
tsA201 human cell line and characterized using the patch clamp
technique in whole-cell conﬁguration as already reported [14].Fig. 1. Molecular identiﬁcation of S1333Y. (A) DHPLC elution proﬁles of S1333Y identiﬁ
exon 23 of SCN5A at 61.1, 61.3, and 62.5 C. (C) Sequencing analysis showing a C-to-A
substitution at residue 1333.2.4. Solutions and reagents
For the whole-cell recordings, the patch pipettes were ﬁlled
with 35 mM NaCl, 105 mM CsF, 10 mM EGTA, and 10 mM Cs-
HEPES. The pH was adjusted to 7.4 using 1 N CsOH. The bath solu-
tion contained 150 mM NaCl, 2 mM KCl, 1.5 mM CaCl2, 1 mM
MgCl2, 10 mM glucose, and 10 mMNa-HEPES. The pH was adjusted
to pH 7.4 using 1 N NaOH (ﬁnal Na+: 152.4 mM). The liquid junc-
tion potential between the patch pipette and the bath solution
was corrected to 7 mV.
2.5. Statistical analysis
Results are presented as means ± standard errors of the mean.
Statistical comparisons were made using the unpaired Student’s
t-test in SigmaStat (Jandel Scientiﬁc Software, San Rafael, CA,
USA). Differences were considered signiﬁcant at P < 0.05.
3. Results
3.1. Identiﬁcation of the SCN5A mutation S1333Y
The genomic DNA of the SIDS infant was screened for sequence
changes in all 28 exons of SCN5A by DHPLC analysis. The PCR anal-
ysis of the SCN5A gene revealed a mutation that was a compound
heterozygote with SCN5A/S1333Y and KCNE1/T20I (Fig. 1A and B).
The family members of the infant were screened clinically and
genetically. SCN5A/S1333Y was a spontaneous mutation and the
father was found to be the carrier of the KCNE1/T20I mutation with
no LQTS-related phenotypes. Other family members were negative
in the screen. It was hypothesized that the S1333Y mutation ised in exon 23 of SCN5A at 62.5 C. (B) DHPLC elution proﬁle of S1333Y identiﬁed in
substitution at position 3998 in exon 23, leading to a serine (S)-to-tyrosine (T)
892 H. Huang et al. / FEBS Letters 583 (2009) 890–896responsible for the sudden death event in the patient. The sequenc-
ing analysis revealed a heterozygous C-to-A base change at posi-
tion 3998 in exon 23 that resulted in a serine (S)-to-tyrosine (Y)
substitution at residue 1333 (Fig. 1C). The mutation was in the
S4–S5 linker in domain III, which plays a major role in fast inacti-
vation of the Na+ channel. This amino acid is highly conserved in
the Na+ channels of many species.
3.2. Biophysical characteristics of Nav1.5/S1333Y
Whole-cell Na+ currents were elicited by depolarizing steps
from 100 to +50 mV with a holding potential of 140 mV20
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Fig. 2. Analysis of whole-cell currents recorded from tsA201 cells expressing WT and S1
from 100 mV to +50 mV in 10 mV increment for each step. (B) Current–voltage relation
to the membrane capacitance. (C) The voltage-dependent time constants of inactivation in
sslow, n = 8). Currents were ﬁtted to a two-exponential function, obtaining the correspon(Fig. 2A). Current amplitudes were normalized to cellular mem-
brane capacitance to generate current–voltage (I–V) curves in the
form of current densities. Using the same data and graphically
determined reversal potentials, the Na+ conductance for the vari-
ous voltages was calculated from the equation G = I/(V  Erev),
where I is the peak Na+ current at a given voltage V and Erev, the
equilibrium potential extrapolated from the graph. I–V and con-
ductance–voltage (G–V) curves were obtained for S1333Y and
WT. The S1333Y mutant and WT channels had similar current den-
sities, suggesting that they were expressed to the same extent on
the cell membrane (Fig. 2B). The potential of the maximum peak
current amplitude of the S1333Y channel was more negative thanNav1.5/S1333Y
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alteration of steady-state activation and inactivation. To analyze
the effect of the S1333Y mutation on fast inactivation kinetics,
the time constant s was measured by ﬁtting the decay of the
whole-cell current elicited at each potential with the followingFig. 3. The gating properties of steady-state activation and inactivation, and
window currents. (A) Voltage-dependence of steady-state activation and inactiva-
tion in WT (M for activation, n = 9 and  for inactivation, n = 9) and S1333Y (N for
activation, n = 8 and d for inactivation, n = 8). The activated and inactivated
currents were generated from the protocols as inset, and their resulting data were
ﬁtted to a standard Boltzmann distribution. (B) The enlarged portion of overlap area
(light grey) between activation and inactivation for WT. The shaded area represents
the window region. (C) The enlarged part of overlap area (dark grey) between
activation and inactivation for S1333Y. The shaded area was signiﬁcantly enhanced
than that of WT.double-exponential function: I = Iresid + Afast  exp((t  k)/sfast) +
Aslow  exp((t  k)/sslow), where I is the current density, Iresid the
steady-state asymptotic residue, Afast and Aslow are the percentages
of channels inactivating with time constants sfast and sslow, and k is
the time shift. Depolarizing steps from 2 to 50 ms were tested to
ensure full current decay and the best ﬁt. The S1333Y channel
had a signiﬁcantly longer time constant for the slow component
than the WT channel over the entire voltage range from 70 mV
to +10 mV (Fig. 2C). The most signiﬁcant difference was at
20 mV, where the time constant sslow was 8.56 ± 0.54 ms (n = 8)
for S1333Y and 4.67 ± 0.36 ms (n = 9) for WT. The slower decay
of sslow indicated a decelerated inactivation of open channels. G–
V curves were ﬁtted to a standard Boltzmann distribution G(V)/
Gmax = 1/(1 + exp((V  V1/2)/k)), where G(V) is the conductance
at a given voltage V and Gmax is the maximum conductance. The
midpoint of activation voltage (V1/2) and the slope factor (k) were
determined from the ﬁt. The steady-state activation of the
S1333Y mutation was negatively shifted by 8 mV, with no differ-
ence in the slope factor (Fig. 3A, and values in Table 1).
Voltage-dependent steady-state inactivation was measured by
applying 500 ms pre-pulses ranging from 140 to 30 mV, fol-
lowed by a 20 ms test pulse at 30 mV. The test pulse current
amplitude was normalized to the maximum current recorded dur-
ing the pre-pulse and plotted versus the pre-pulse voltage to ob-
tain the voltage-dependent inactivation curve, which was ﬁtted
to a standard Boltzmann distribution function I(V)/Imax = 1/(1 + ex-
p((V  V1/2)/k)), where I(V)/Imax is the current ratio and V, the pre-
pulse voltage. During steady-state inactivation, a + 7 mV shift for
S1333Y was observed, but the slope factor was not signiﬁcantly af-
fected (Fig. 3A). V1/2 and k were generated by ﬁtting each data set
with the standard Boltzmann function (see Table 1 for values).
Steady-state activation and inactivation shifts appeared to in-
crease the window current for S1333Y, which is generated by the
overlap between these two ﬁtting curves (Fig. 3B and C). The win-
dow current in LQT3 is associated with steady-state Na+ channels
reopening. S1333Y (Fig. 3C) signiﬁcantly enhanced area of the win-
dow current compared to WT (Fig. 3B).
During slow inactivation, some voltage-gated Na+ channels be-
come non-conducting following prolonged membrane depolariza-
tion. The course of slow inactivation was assessed using a two-
pulse protocol with an initial conditioning pre-pulse and a ﬁnalTable 1
Biophysical properties of Nav1.5/WT and Nav1.5/S1333Y.
Nav1.5/WT Nav1.5/S1333Y
Steady-state activation
V1/2 (mV) 50.34 ± 2.06 (n = 9) 58.88 ± 1.25* (n = 8)
K (mV) 6.38 ± 0.27 (n = 9) 6.13 ± 0.34 (n = 8)
Steady-state inactivation
V1/2 (mV) 100.47 ± 1.34 (n = 9) 93.46 ± 0.66** (n = 8)
K (mV) 4.91 ± 0.19 (n = 9) 4.91 ± 0.21 (n = 8)
Slow inactivation
s (ms) 327.78 ± 37.10 (n = 8) 306.96 ± 22.87 (n = 9)
Recovery from slow inactivation
sfast (ms) 16.49 ± 4.73 (n = 7) 4.08 ± 0.60** (n = 7)
sslow (ms) 251.81 ± 60.79 (n = 7) 104.41 ± 27.06* (n = 7)
Afast 91.7 ± 0.82% (n = 7) 94.33 ± 0.72% (n = 7)
Aslow 8.3 ± 0.82% (n = 7) 5.67 ± 0.72% (n = 7)
Closed-state inactivation
110 mV
s (ms) 89.54 ± 10.76 (n = 9) 60.28 ± 4.11* (n = 9)
100 mV
s (ms) 109.51 ± 14.12 (n = 9) 65.82 ± 5.33** (n = 10)
V1/2 = midpoint for activation or inactivation; Kv = slow factor for activation or
inactivation; s = time constant; and A = fraction of recovery component.
* P < 0.05.
** P < 0.01.
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from 2 to 1000 ms, followed by a step to 140 mV for 20 ms to al-
low the channels to recover from fast inactivation. The 30 mV
test pulse was applied for 40 ms to estimate the fraction of chan-Time (ms)
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Fig. 4. The gating properties of slow inactivation, recovery from slow inactivation,
and closed-state inactivation. (A) Slow inactivation inWT (, n = 8) and S1333Y (,
n = 9). A two-pulse protocol as inset was used to generate the currents. The time
constants (shown in Table 1) were obtained using a mono-exponential function. (B)
Time courses of recovery from slow inactivation in WT (, n = 7) and S1333Y (,
n = 7). A 500 ms conditioning pre-pulse was used to monitor recovery by a 20 ms
test pulse after a variable recovery interval from 1 to 2000 ms (see protocol in
inset). The time constants were obtained using a two-exponential function. (C)
Closed-state inactivation in WT ( for 110 mV, n = 9 andM for 100 mV, n = 9)
and S1333Y ( for 110 mV, n = 9 and N for 100 mV, n = 10). The protocol in
inset elicited the currents, which were ﬁtted to a mono-exponential function.nels available for activation. The fraction was obtained by dividing
the current amplitude during the test pulse by the current ampli-
tude during the pre-pulse. Entry into slow inactivation followed
a mono-exponential function I = Iresid + A  exp(t/s), where I is
the current intensity, Iresid the asymptotic residual current, and A
the current amplitude at time zero (see values in Table 1). As
shown in Fig. 4A, there was no signiﬁcant difference in the kinetics
of entry into slow inactivation between the S1333Y mutation and
WT. Recovery from slow inactivation was measured using a two-
pulse protocol, where Na+ channels were inactivated by aFig. 5. Effect of TTX on the persistent sodium current in WT and S1333Y. The
persistent sodium current was generated from a holding potential of +140 mV to
30 mV over 400 ms (see protocol in inset). The dashed line represents zero
current. (A) Effect of adding 5 lM TTX to WT for 10 min. (B) Effect of adding 5 lM
TTX to S1333Y for 10 min. The persistent sodium current was blocked by TTX. (C)
The histogram of the persistent sodium current. The persistent sodium current
accounted for 0.27 ± 0.14% of the peak current amplitude for WT (n = 5) and
1.16 ± 0.22% for S1333Y (n = 6) at 30 mV (**P < 0.01).
H. Huang et al. / FEBS Letters 583 (2009) 890–896 89530 mV conditioning pulse for 500 ms, followed by a 30 mV test
pulse after a recovery interval varying from 1 to 2000 ms. The peak
current in response to the test pulse was normalized to the
maximum peak current in response to the conditioning pulse.
The normalized current was plotted against the recovery time
interval. The resulting curve was ﬁtted to a double-exponential
function to obtain the following fast and slow components of
recovery from slow inactivation: INa = Af  (1  exp[t/sf]) + As 
(1  exp[t/ss]), where t is the recovery time interval, sf and sf,
the time constants of the fast and slow components, and Af and
As, the fractions of the fast and slow components (see values in Ta-
ble 1). The results shown in Fig. 4B indicate that S1333Y recovered
more rapidly from slow inactivation than WT.
The positive shift of the steady-state inactivation may be the re-
sult of fewer channels entering into closed-state inactivation
(Fig. 4C). Closed-state inactivation primarily affects the availability
of channels at voltages near the resting membrane potential, thus
controlling the Na+ current amplitude of the action potential. Using
a double-pulse protocol, cells were pre-pulsed to 110 and
100 mV for periods ranging from 1 to 500 ms, and then stepped
to 30 mV to determine the availability of INa during the pre-pulse.
The time course was ﬁtted with the following mono-exponential
equation: I = Iresid + A  exp(t/s) (see values in Table 1).
Whole-cell Na+ currents recorded in tsA201 cells expressing the
WT SCN5A gene can exhibit a small persistent component whose
magnitude depends on the recording conditions. The increased
persistent Na+ current in LQT3 mutants is a major factor in the pro-Fig. 6. Effect of lidocaine on the persistent sodium current in WT and S1333Y. The
persistent sodium current was generated from a holding potential of +140 mV to
30 mV for 400 ms (see protocol as inset). The dashed line represents zero current.
(A) Effect on WT of an 8-min treatment with 200 lM lidocaine on WT. (B) Effect on
S1333Y of an 8-min treatment with 200 lM lidocaine. The persistent sodium
current was blocked by lidocaine.longation of the QT interval. To study the contribution of the per-
sistent current at steady-state, we measured the current using a
400 ms depolarization pulse. The persistent current was barely
detectable in cells expressing WT channels (Iper/Ipeak = 0.27 ± 0.14%,
n = 5), while there was a signiﬁcant increase in the persistent cur-
rent in cells expressing the S1333Y mutation (Iper/Ipeak = 1.16 ±
0.22%, n = 6) (Fig. 5C). Class I B Na+ channel blockers (e.g., lido-
caine) were reported to normalize prolonged QTc in LQT3 patients
[15]. We therefore investigated the effect of lidocaine on the per-
sistent inward Na+ current of the S1333Y mutation. The persistent
currents in WT and S1333Y were both blocked by 5 lM tetrodo-
toxin (TTX) (Fig. 5A and B) and 200 lM lidocaine (Fig. 6A and B),
respectively.4. Discussion
In the present study, we biophysically characterized a new
SCN5A mutation (S1333Y) in an infant who had died of SIDS. The
mutation was located in the S4–S5 linker of domain III, which is of-
ten associated with inactivation changes in voltage-dependent Na+
channels. The electrophysiological studies showed persistent Na+
inward currents accompanied by a 8 mV shift in activation, and
a +7 mV shift in inactivation. The window current was therefore
enhanced by the shifts of activation and inactivation. The slow
component of the fast activation of macroscopic currents of the
mutation was slower than that of the WT. The serine at position
1333 is highly conserved, suggesting that this residue may play
an important role in the channel gating.
Some inherited arrhythmic disorders (e.g., Brugada syndrome
(BrS) and LQTS) appear to be associated with SIDS because they
may explain the increased likelihood of sudden death when a trig-
ger event occurs. Since the gating properties of BrS mutations are
characterized by a loss of the Na+ channel function, the present
case is unlikely to be related to BrS.
The S1333Y mutation caused a serine-to-tyrosine substitution
in the S4–S5 linker of domain III, which is near the proposed dock-
ing site of the inactivation particle. This mutation caused similar
alterations in activation, fast inactivation, and kinetics of fast inac-
tivation. Many LQT3 mutations have a persistent Na+ current along
with shortened fast inactivation time constants. However, R1623Q
showed a slower rate of current decay that is in agreement with
our results [16]. Reduced closed-state inactivation is consistent
with the positive shift of inactivation. The rate of recovery from
inactivation was also faster, which is in agreement with the ﬁnd-
ings reported for LQT3 mutations (DKPQ, R1644H, and E1784K)
[14,17,18]. Faster recovery may increase the channel availability
at the resting membrane potential of the ventricular cells. The
shifts of activation and inactivation of the mutant enhanced the
window current and an action potential could be triggered in this
narrow region, The enhanced window currents can increase the
risk of fatal ventricular arrhythmias especially when they coexist
with persistent inward Na+ currents. The A1330P SCN5A mutation,
which also causes SIDS, is located near the site of the S1333Ymuta-
tion. A1330P causes a gain of Na+ channel function by signiﬁcantly
increasing the window current. Interestingly, this mutation does
not induce a persistent Na+ current [7].
Mutations in the Na+ channel associated with LQT3 usually re-
sult in a persistent Na+ current ﬂowing during the plateau phase
of the cardiac action potential. At least ﬁve LQT3 mutations
(S941N, A1330P, S1103Y, R1826H, and A997S) have been associ-
ated with SIDS [6–9]. Of these, two (R1826H and A997S) have a
persistent inward Na+ current. Moreover, in studies on relation-
ships between cardiac polymorphisms and SIDS, a persistent Na+
current was found in ﬁve of eight variants [19]. Such a persistent
current may cause slower inactivation, resulting in prolonged
896 H. Huang et al. / FEBS Letters 583 (2009) 890–896repolarization and thus a long QT interval. In the present study, the
S1333Y mutation caused a persistent current that accounted for
1.16 ± 0.22% of the current amplitude. While there are no docu-
mented clinic ﬁndings to support the diagnosis of LQTS, we suspect
that fatal ventricular arrhythmia may be triggered by an event
such as the prone position during sleep.
We also found that the persistent current induced by S1333Y
was sensitive to lidocaine. This suggests that the prolonged QT
interval could be normalized by class I B Na+ channel blockers.
The mechanism of blocking the persistent current may be acted
by lidocaine stabilizing inactivation, and thereby reducing the
probability of dispersed and bursting activities in LQT3 mutant
channels [20].
In the case presented here, sudden death occurred 25 days after
delivery, and resuscitatory efforts were not possible given that
SIDS happened too quickly. To prevent the sudden death event, a
more effective way would be to diagnose the condition soon after
delivery using the ECG that is faster and less expensive to perform.
For those with a family history of SIDS and bradycardia, genetic
analyses are recommended when the QTc exceeds 440 ms [8,21].
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